A new Alzheimer’s treatment is showing promising initial results in early clinical trials. Published in a study in Nature Medicine, researchers from Western University, Stanford University and the University of California, San Francisco, have evaluated the effectiveness of a drug that is for now called LM11A-31, which targets a specific neurotrophin receptor. According to the […]